Cyduct Diagnostics Inc
CYduct Diagnostics, Inc., a healthcare company, develops, produces, and markets medical devices for the assessment, identification, diagnosis and treatment of breast cancer. The company offers HALO system, a noninvasive device that utilizes proprietary technology to obtain breast fluid; and MammoView, a fiberoptic technology with the ability to view and collect cells and other abnormalities. It a… Read more
Market Cap & Net Worth: Cyduct Diagnostics Inc (CYDX)
Cyduct Diagnostics Inc (PINK:CYDX) has a market capitalization of $1.06 Million ($1.06 Million) as of March 19, 2026. Listed on the PINK stock exchange, this USA-based company holds position #47340 globally and #14653 in its home market, demonstrating a 0.00% increase in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying Cyduct Diagnostics Inc's stock price $0.20 by its total outstanding shares 5240857 (5.24 Million).
Cyduct Diagnostics Inc Market Cap History: 2020 to 2025
Cyduct Diagnostics Inc's market capitalization history from 2020 to 2025. Data shows change from $3.25 Million to $1.06 Million (-21.07% CAGR).
Cyduct Diagnostics Inc Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how Cyduct Diagnostics Inc's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance.
Latest Price to Sales (P/S) Ratio
14.98x
Cyduct Diagnostics Inc's market cap is 14.98 times its annual revenue
0.67x
Higher than industry averageLatest Price to Earnings (P/E) Ratio
N/A
P/E ratio not applicable due to negative or zero earnings
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| 2020 | $3.25 Million | $194.44K | $559.05K | 16.71x | 5.81x |
| 2021 | $5.24 Million | $160.83K | -$372.03K | 32.59x | N/A |
| 2022 | $1.64 Million | $94.05K | -$420.49K | 17.45x | N/A |
| 2023 | $2.67 Million | $119.34K | -$472.74K | 22.40x | N/A |
| 2024 | $791.89K | $84.48K | -$418.03K | 9.37x | N/A |
| 2025 | $1.06 Million | $70.69K | -$413.61K | 14.98x | N/A |
Competitor Companies of CYDX by Market Capitalization
Companies near Cyduct Diagnostics Inc in the global market cap rankings as of March 19, 2026.
Key companies related to Cyduct Diagnostics Inc by market ranking:
- Abbott Laboratories (NYSE:ABT): Ranked #78 globally with a market cap of $191.37 Billion USD.
- Stryker Corporation (NYSE:SYK): Ranked #154 globally with a market cap of $121.03 Billion USD.
- Medtronic PLC (NYSE:MDT): Ranked #168 globally with a market cap of $113.17 Billion USD.
- Boston Scientific Corp (NYSE:BSX): Ranked #185 globally with a market cap of $105.26 Billion USD.
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #78 | Abbott Laboratories | NYSE:ABT | $191.37 Billion | $110.71 |
| #154 | Stryker Corporation | NYSE:SYK | $121.03 Billion | $349.11 |
| #168 | Medtronic PLC | NYSE:MDT | $113.17 Billion | $88.44 |
| #185 | Boston Scientific Corp | NYSE:BSX | $105.26 Billion | $71.20 |
Cyduct Diagnostics Inc Historical Marketcap From 2020 to 2025
Between 2020 and today, Cyduct Diagnostics Inc's market cap moved from $3.25 Million to $ 1.06 Million, with a yearly change of -21.07%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2025 | $1.06 Million | +33.75% |
| 2024 | $791.89K | -70.37% |
| 2023 | $2.67 Million | +62.89% |
| 2022 | $1.64 Million | -68.69% |
| 2021 | $5.24 Million | +61.29% |
| 2020 | $3.25 Million | -- |
End of Day Market Cap According to Different Sources
On Mar 18th, 2026 the market cap of Cyduct Diagnostics Inc was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $1.06 Million USD |
| MoneyControl | $1.06 Million USD |
| MarketWatch | $1.06 Million USD |
| marketcap.company | $1.06 Million USD |
| Reuters | $1.06 Million USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.